The below Parliamentary question was asked by David Amess on 2016-01-07.
To ask the Secretary of State for Health, how many technologies have been assessed through NHS England’s commissioning through evaluation process in (a) 2014 and (b) 2015.
George Freeman
In 2014, five treatments commencedevaluation under NHS England’s Commissioning through Evaluation programme.
In 2015, six treatments commenced evaluation under NHS England’s Commissioning through Evaluation programme.
The below Parliamentary question was asked by David Amess on 2016-01-07.
To ask the Secretary of State for Health, what proportion of medicines selected by NHS England Clinical Reference Groups for the development of commissioning policies have been (a) approved and (b) not approved by each Programme of Care board.
George Freeman
National Programmes of Care boards do not approve or decline proposed investments in specialised services.
Decisions on proposed investments are made by NHS England’s Specialised Commissioning Oversight Group and the Specialised Commissioning Committee following recommendations from the Clinical Priorities Advisory Group.
National Programmes of Care boards provide assurance that proper process has been followed in the development of proposals for consideration.
The below Parliamentary question was asked by Sadiq Khan on 2016-01-07.
To ask the Secretary of State for Health, how many delays of over 12 hours there were in each A&E department in London in each year since 2010.
Jane Ellison
The information is not available in the format requested. Information is available on the number of patients spending more than 12 hours from decision to admit to admission in each accident and emergency department in London by year. This can be found at the following website:
https://www.england.nhs.uk/statistics/statistical-work-areas/ae-waiting-times-and-activity/
“
The below Parliamentary question was asked by Sadiq Khan on 2016-01-07.
To ask the Secretary of State for Health, what proportion of patients were seen within four hours of arriving at each A&E department in London in December (a) 2010, (b) 2011, (c) 2012, (d) 2013, (e) 2014 and (f) 2015.
Jane Ellison
The information is not available in the format requested. Information is available on the percentage of patients that were admitted, transferred or discharged within four hours of arriving at each accident and emergency department in London in December by year. December 2015 data has not been collected yet. This can be found at the following website:
https://www.england.nhs.uk/statistics/statistical-work-areas/ae-waiting-times-and-activity/
“
The below Parliamentary question was asked by Tristram Hunt on 2016-01-07.
To ask the Secretary of State for Health, how many jobs in (a) his Department and (b) each of its non-departmental public bodies, executive agencies, non-ministerial departments, advisory bodies and other accountable statutory bodies (i) have been abolished or relocated from Stoke-on-Trent since 2010 and (ii) will be abolished in or relocated from Stoke-on-Trent by 2020.
Jane Ellison
Information about the number of jobs that (i) have been abolished or relocated from Stoke-on-Trent since 2010 and (ii) will be abolished in or relocated from Stoke-on-Trent by 2020 is set out in the attached tables. The information about non-Departmental public bodies, executive agencies, and other accountable statutory bodies is not held centrally by the Department and their information, as indicated below, has been provided by those bodies.
The below Parliamentary question was asked by Greg Mulholland on 2016-01-07.
To ask the Secretary of State for Health, what steps he is taking to made the drug Everolimus available on the NHS for treating the subependymal giant cell astrocytoma form of tuberous sclerosis complex.
George Freeman
A policy for the provision of Everolimus for Tuberous Sclerosis forComplex Related Renal Angiomyolipoma anda policy for the provision of Everolimusfor SubependymalGiant Cell Astrocytoma are currently in development. Once completed, each policy will need to be considered by the relevant clinical panels, the Clinical Priorities Advisory Group and the Specialised Commissioning Oversight Group.
It is NHS England’s intention that the policies will be published by the end of the financial year.
The below Parliamentary question was asked by Sadiq Khan on 2016-01-07.
To ask the Secretary of State for Health, how many and what proportion of elective operations were cancelled in (a) England and Wales, (b) London and (c) each health trust in England in each year since 2010.
Jane Ellison
Information on cancelled elective operations is published quarterly. The attached table shows how many elective operations were cancelled in England, London and each health trust in England in each quarter since 2010. Information on the number of cancelled elective operations as a percentage of elective admissions is only published for England.
The number and proportion of cancelled operations remains low in the context of the millions of operations performed in the National Health Service each year. Compared to 2009/10, in 2014/15 there were 1.6 million more operations. The proportion of cancelled elective operations in the first two quarters of 2015/16 was 0.8% which is the same as the first two quarters of 2009/10.
Health is a devolved matter in Wales.
The below Parliamentary question was asked by Sadiq Khan on 2016-01-07.
To ask the Secretary of State for Health, what the end of financial year budget surpluses or deficits was for each health trust in London in each year since 2010.
Alistair Burt
The information requested is in the attached tables.
The below Parliamentary question was asked by David Amess on 2016-01-07.
To ask the Secretary of State for Health, how many highly specialised technologies are currently being assessed by the NHS England highly specialised technologies assessment process.
George Freeman
NHS England is currently developing a refined process for the prioritisation of proposed new investments in specialised services and highly specialised services.
The number of technologies to be routinely commissioned by NHS England will be determined by the new process.
The below Parliamentary question was asked by David Amess on 2016-01-07.
To ask the Secretary of State for Health, how many highly specialised technologies are awaiting assessment by NHS England which were not selected for consideration by NICE’s highly specialised technology appraisal process.
George Freeman
NHS England is currently developing a refined process for the prioritisation of proposed new investments in specialised services and highly specialised services.
The number of technologies to be routinely commissioned by NHS England will be determined by the new process.